KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Assets (2016 - 2025)

Neogenomics (NEO) has disclosed Non-Current Assets for 16 consecutive years, with $983.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 5.61% year-over-year to $983.5 million, compared with a TTM value of $983.5 million through Dec 2025, down 5.61%, and an annual FY2025 reading of $983.5 million, down 5.61% over the prior year.
  • Non-Current Assets was $983.5 million for Q4 2025 at Neogenomics, down from $992.3 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.2 billion in Q3 2021 and bottomed at $551.7 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets skyrocketed 123.09% in 2021, then fell 5.61% in 2025.
  • Year by year, Non-Current Assets stood at $1.2 billion in 2021, then dropped by 4.5% to $1.1 billion in 2022, then decreased by 4.44% to $1.1 billion in 2023, then decreased by 3.91% to $1.0 billion in 2024, then fell by 5.61% to $983.5 million in 2025.
  • Business Quant data shows Non-Current Assets for NEO at $983.5 million in Q4 2025, $992.3 million in Q3 2025, and $1.0 billion in Q2 2025.